http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10167985-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06 |
| filingDate | 1997-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f8ee1a1b758be1b8256f30bd6dd43a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aef1d791a6fa0e7c72d4f5327a8ccc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aab07faabc8aaa0906145ed122a5288a |
| publicationDate | 1998-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H10167985-A |
| titleOfInvention | Anti-Helicobacter |
| abstract | (57) [Problem] To provide a drug which has a small burden on a patient and has an excellent anti-Helicobacter action. An anti-Helicobacter agent containing a lipid selected from hydrogenated oil, carnauba wax and microcrystalline wax, a viscous substance, and an antibacterial substance (excluding a condensed imidazole compound) as the only active ingredient is used. [Effect] The anti-Helicobacter agent of the present invention adheres to the gastrointestinal mucosa and has a long residence time in the gastrointestinal tract, and can maintain the pharmacological activity of the antibacterial substance in a small dose, thereby reducing side effects. It is characterized by a low burden on the user. Therefore, the anti-Helicobacter agent of the present invention is a disease caused by Helicobacter spp. Duodenal ulcer, gastric ulcer, anastomotic ulcer, gastritis, esophagitis, reflux esophagitis, Zollinger-Ellison son) syndrome, gastric cancer, liver cancer, etc.) can be used safely as a preventive / therapeutic agent. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018149269-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004089378-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6582720-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6653333-B2 |
| priorityDate | 1996-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 102.